Method of adjuvant cancer treatment
US10869869B2 · kind B2 · utility
8Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 28, 2019 |
| Grant date | Dec 22, 2020 |
| Priority date | — |
| Expiry date | Oct 28, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of providing adjuvant treatment to a human patient which comprises administering to such a patient therapeutically effective doses of dabrafenib and trametinib for a time period sufficient to increase relapse-free survival (RFS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.